Earlier this week, pharmaceutical company Pfizer and its partner Valneva announced that an experimental Lyme disease vaccine ...

Pfizer (NYSE:PFE) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over the past year. The ...

U.S. stock indexes slipped and gave back some of their rallies from the day before, while oil prices got back to rising. The S&P 500 fell 0.4% Tuesday after yo-yoing through the day. The Dow ...

Protalix BioTherapeutics, Inc. is rated a Buy due to robust FY26 revenue guidance of $78–83 million. Learn more about PLX ...

Shares of Valneva VALN tanked 37% on Monday after the company reported top-line results from the phase III VALOR study, which ...

The UK meningitis outbreak may worsen in coming weeks and months, with further contamination unrelated to the southeastern ...

Detailed price information for Telescope Innovations Cp (TELIF) from The Globe and Mail including charting and trades.